Cancer and thrombosis: from molecular mechanisms to clinical presentations
- 1 July 2007
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (s1), 246-254
- https://doi.org/10.1111/j.1538-7836.2007.02497.x
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signalingJCI Insight, 2006
- Thrombosis and Cancer: The Role of Screening for Occult Cancer and Recognizing the Underlying Biological MechanismsHematology-American Society Hematology Education Program, 2006
- The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivoThrombosis and Haemostasis, 2006
- Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and CancerArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Cancer and venous thromboembolismThe Lancet Oncology, 2005
- Antiapoptotic effect of coagulation factor VIIaBlood, 2003
- Incidence of symptomatic venous thromboembolism after different elective or urgent surgical proceduresThrombosis and Haemostasis, 2003
- Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectinsJCI Insight, 2002
- A Role for Tissue Factor in Cell Adhesion and Migration Mediated by Interaction with Actin-binding Protein 280The Journal of cell biology, 1998
- The plasminogen-plasmin system in malignancyCancer and Metastasis Reviews, 1992